Zealand Pharma Financial Overview
Zealand Pharma's market cap is currently $5.30B. The company's EPS TTM is $-0.9011745; its P/E ratio is 5.18; Zealand Pharma is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.
